Publication
International Restructuring Newswire
Welcome to the Q2 2024 edition of the Norton Rose Fulbright International Restructuring Newswire.
Global | Publication | April 2018
On December 14, 2017, the Commissioner of the US Food and Drug Administration (FDA), Dr. Scott Gottlieb, posted Looking ahead: Some of FDA’s major policy goals for 2018 on FDA’s blog, FDA Voice, and discussed FDA’s policy agenda published on the Unified Agenda of Federal Regulatory and Deregulatory Actions (Unified Agenda), which provides the public with insight into regulations under development or review throughout the federal government. In the Unified Agenda, FDA outlines some of its efforts to modernize its approach and improve its efficiency, while protecting and promoting the public health and upholding FDA’s “gold standard” for regulatory decisionmaking. Gottlieb discussed the FDA’s contributions to the Fall 2017 Unified Agenda, which address a number of areas of policymaking underway at the agency, and are directly aligned with the FDA’s major priorities
Gottlieb stressed that just because a previously identified regulation does not appear on this Unified Agenda submission does not necessarily mean the agency does not consider it a priority or will not continue to consider it moving forward. Over the next year, the FDA will address many additional priority areas,including efforts to reduce the cost of drugs by encouraging competition, spur innovation across medical products, give consumers access to clear and consistent nutrition information, create greater regulatory efficiencies in bringing products to market, and put a dent in the country’s opioid addiction crisis. The Health Law Pulse will continue to monitor for additional information about the many initiatives identified in the Fall 2017 Unified Agenda. Special thanks to Robert Kantrowitz* for his assistance in drafting this post.
*Law Clerk–not admitted to practice law.
Publication
Welcome to the Q2 2024 edition of the Norton Rose Fulbright International Restructuring Newswire.
Publication
n a long-running dispute, taking in no less than three arbitrations spanning 26 years cumulatively (involving allegations of state interference in the arbitral process), the Court has provided useful guidance on the ss.67 and 68 challenges, particularly in the context of investor-state claims.
Publication
Our Asia Competition Law facts sheets provide insights into the main competition law regimes across Asia, reflecting the experience and reach of our Asia competition team in an ever changing and increasingly complex competition law environment.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023